Our Mission
To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. Since its founding in 1946, Damon Runyon has invested nearly $355 million and funded nearly 3,700 young scientists.
yung S. lie, phd, named Damon Runyon's next leader
Yung S. Lie, PhD, was appointed the incoming President and Chief Executive Officer of the Damon Runyon Cancer Research Foundation. Dr. Lie succeeds Lorraine W. Egan, who will step down in December. Read about Dr. Lie, a former Damon Runyon fellow, as she leads our efforts to end cancer.
Race to the Top of Salesforce Tower Benefits Cancer Research
Approximately 450 supporters took part in Runyon Up, the first fundraising stair climb held at the newly opened Salesforce Tower in San Francisco on October 21. Climbers faced a unique vertical challenge in the 61-story building, the tallest in San Francisco, and were rewarded with breathtaking views from the top.
from the lab to patients
Congratulations 2018 Nobel Prize winners, James P. Allison and Tasuku Honjo, for their discovery that certain proteins act as “brakes” on the immune system, limiting its ability to attack cancer cells. Learn about the Damon Runyon scientists, who have made critical discoveries that helped bring a new class of drugs to patients based on this discovery.
